The Effect of Hyperoxia on Ventilation During Recovery From General Anesthesia
Launched by STANFORD UNIVERSITY · May 12, 2022
Trial Information
Current as of August 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how extra oxygen helps people breathe better after they wake up from general anesthesia. Researchers want to see if providing more oxygen for 90 minutes right after the breathing tube is removed can improve recovery and reduce the risk of breathing problems after surgeries like kidney or prostate removal using robotic techniques.
To participate in the trial, patients should be between 18 and 80 years old and generally healthy, with a body mass index (BMI) of less than 40. They should not have serious lung issues, major neurological or heart problems, or be on strong pain medications like opioids. If eligible, participants will receive oxygen or regular air after their surgery and will be monitored to see how well they breathe during the recovery period. This study aims to find out if extra oxygen can make a difference in recovery after surgery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • American Society of Anesthesiologists (ASA) physical status I-III
- • Body mass index (BMI) less than 40 kg/m2
- • Scheduled to undergo robotic-assisted radical laparoscopic nephrectomy or prostatectomy.
- Exclusion Criteria:
- • Patients with a diagnosis of chronic obstructive pulmonary disorder (COPD), severe neurological, cardiopulmonary, psychiatric, or untreated thyroid disorder
- • Chronic pain condition that is being treated with opioids
- • Patients with a hematocrit lower than 30% at the end of surgery, or those with an excessive blood loss, requiring transfusion of blood products during surgery.
About Stanford University
Stanford University is a prestigious academic institution renowned for its cutting-edge research and innovation in healthcare and medicine. As a clinical trial sponsor, Stanford leverages its extensive resources, including a collaborative network of world-class researchers and state-of-the-art facilities, to advance medical knowledge and improve patient care. The university is committed to conducting rigorous, ethical research that adheres to the highest standards of scientific integrity, fostering an environment where groundbreaking discoveries can translate into effective clinical applications. Through its clinical trials, Stanford aims to address critical health challenges and contribute to the development of novel therapies and treatment strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Stanford, California, United States
Patients applied
Trial Officials
Anthony Doufas, MD, PhD
Principal Investigator
Professor, Department of Anesthesiology, Stanford University Medical School
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials